Antibiotic Selection in Childhood Urinary System Infections

Selim ÖNCELa , Yeliz TANRIVERDİ ÇAYCIb , Mustafa ALTINDİŞc

aKocaeli University Faculty of Medicine, Division of Pediatric Infectious Diseases, Sakarya, Türkiye
bOndokuz Mayıs University Faculty of Medicine, Department of Medical Microbiology, Samsun, Türkiye
cSakarya University Faculty of Medicine, Department of Medical Virology, Sakarya, Türkiye

ABSTRACT

Urinary tract infections (UTI) are the most common bacterial infections among childhood infectious diseases. The most common causative organism is Escherichia coli. Both host and microbial factors play a role in the development of UTI. UTI is diagnosed by midstream urine collection in older children, and by catheterization, suprapubic aspiration and urine bag collection are used in younger children. The main diagnostic tests are urinalysis and urine culture. Post-culture antibiogram is important to determine the correct treatment. In recent years there has been an increase in resistance to ampicillin, ampicillin-sulbactam, amoxicillin-clavulanic acid, trimetoprim-sulphametaxazol and cephalosporins, which are the drugs of choice, is remarkable. Therefore, monitoring regional antimicrobial susceptibility data is important for appropriate treatment planning.

Keywords: Urinary tract infections; child; newborn, infant; microbiology

Referanslar

  1. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med. 2011;365(3):239-50. [Crossref]
  2. Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever. J Pediatr. 1994;124(4):513-9. [Crossref]
  3. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128(3):595-610. [Crossref]
  4. Cataldi L, Zaffanello M, Gnarra M, Fanos V; Neonatal Nephrology Study Group, Italian Society of Neonatology. Urinary tract infection in the newborn and the infant: state of the art. J Matern Fetal Neonatal Med. 2010;23 Suppl 3:90-3. [Crossref]
  5. Sandoval C, Sinaki B, Weiss R, et al. Urinary tract infections in pediatric oncology patients with fever and neutropenia. Pediatr Hematol Oncol. 2012;29(1):68-72. [Crossref]
  6. Spahiu L, Hasbahta V. Most frequent causes of urinary tract infections in children. Med Arh. 2010;64(2):88-90.
  7. Lo DS, Shieh HH, Ragazzi SL, Koch VH, Martinez MB, Gilio AE. Community-acquired urinary tract infection: age and gender-dependent etiology. J Bras Nefrol. 2013;35(2):93-8. [Crossref]
  8. Abrahamsson K, Hansson S, Jodal U, Lincoln K. Staphylococcus saprophyticus urinary tract infections in children. Eur J Pediatr. 1993;152:69-71. [Crossref]
  9. Taşkesen M, Karabay Bayazıt A. Çocuklarda idrar yolu enfeksiyonu. Arşiv 2009;18:57-69.
  10. Bollgren I, Winberg J. The periurethral aerobic flora in girls highly susceptible to urinary infections. Acta Paediatr Scand. 1976;65:81-7. [Crossref]
  11. Hansson S, Jodal U, Noren L, Bjure J. Untreated bacteriuria in asymptomatic girls with renal scarring. Pediatrics. 1989;84:964-8. [Crossref]
  12. O'Brien K, Stanton N, Edwards A, Hood K, Butler CC. Prevalence of urinary tract infection (UTI) in sequential acutely unwell children presenting in primary care: exploratory study. Scand J Prim Health Care. 2011;29:19-22.
  13. Stull TL, LiPuma JJ. Epidemiology and natural history of urinary tract infections in children. Med Clin North Am. 1991;75:287-27. [Crossref]
  14. Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol. 2010;7:430-41. [Crossref]
  15. Spencer JD, Schwaderer AL, Becknell B, Watson J, Hains DS.The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol. 2014;29:1139-49. [Crossref]
  16. Svanborg C. Urinary tract infections in children: microbial virulence versus host susceptibility. Adv Exp Med Biol. 2013;764:205-10. [Crossref]
  17. Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol. 2002;12:33-8. [Crossref]
  18. Yamamoto S. Molecular epidemiology of uropathogenic Escherichia coli. J Infect Chemother. 2007;13:68-73. [Crossref]
  19. Horwitz MA, Silverstein SC. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest. 1980;65:82-94. [Crossref]
  20. Garcia EC, Brumbaugh AR, Mobley HL. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun. 2011;79:1225-35. [Crossref]
  21. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181:261-72. [Crossref]
  22. Kanamaru S, Kurazono H, Ishitoya S, Terai A, Habuchi T, Nakano M, et al. Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol. 2003;170:2490-3. [Crossref]
  23. Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, Koves B, Svanborg C. Genetics of innate immunity and UTI susceptibil-ity. Nat Rev Urol. 2011;8:449-68. [Crossref]
  24. Ragnarsdottir B, Svanborg C. Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol. 2012;27:2017-29. [Crossref]
  25. Cheng CH, Lee YS, Tsau YK, Lin TY. Genetic polymorphisms and susceptibility to parenchymal renal infection among pediatric patients. Pediatr Infect Dis J. 2011;30:309-14. [Crossref]
  26. Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslan-der J. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney. Mediators Inflamm. 2001;10:347-50. [Crossref]
  27. Frendeus B, Godaly G, Hang L, Karpman D, Lundstedt AC, Svan-borg C. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med. 2000;192:881-980. [Crossref]
  28. Zalewska-Piatek BM, Piatek RJ. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains. Acta Biochim Pol. 2019;66:129-38. [Crossref]
  29. Sastre JB, Aparicio AR, Cotallo GD, Colomer BF, Hernandez MC. Grupo de Hospitales Castrillo. Urinary tract infection in the newborn: clinical and radioimaging studies. Pediatr Nephrol. 2007;22:1735-41. [Crossref]
  30. Cleper R, Krause I, Eisenstein B, Davidovits M. Prevalence of vesicoureteral reflux in neonatal urinary tract infection. ClinPediatr (Phila). 2004;43:619-25. [Crossref]
  31. Lohr JA, Donowitz LG, Sadler JE, III. Hospital-acquired urinary tract infection. Pediatrics. 1989;83:193-9.
  32. Doern CD, Richardson SE. Diagnosis of urinary tract infections in children. J Clin Microbiol. 2016; 54:2233-42. [Crossref]
  33. Stein R, Dogan HS, Hoebeke P, Kocvara R, Rien JM et al. Urinary tract infections in children: EAU/ESPU Guidelines. Euorop Uro. 2015;67:546-58. [Crossref]
  34. Smith M, Sanci L. Urinary tract infections in children: an overview of diagnosis and management. BMJ Paediatrics Open 2019;3:e000487. [Crossref]
  35. Herreros Fernández ML, González Merino N, Tagarro García A, et al. A new technique for fast and safe collection of urine in newborns. Arch Dis Child. 2013;98(1):27-9. [Crossref]
  36. Lavelle JM, Blackstone MM, Funari MK, Roper C, Lopez P, Schast A, et al. Two-step process for ED UTI screening in febrile young children: reducing catheterization rates. Pediatrics. 2016;138:e20153023. [Crossref]
  37. [Link]
  38. Chernaya A, Søborg C, Midttun M. Validity of the urinary dipstick test in the diagnosis of urinary tract infections in adults. Dan Med J. 2021;69(1):A07210607.
  39. Nuutinen M, Uhari M. Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol. 2001;16:69-72. [Crossref]
  40. Kapoor DA, Holton MR, Hafron J, Aljundi R, Zwaans B, Hollander M. Comparison of polymerase chain reaction and urine culture in the evaluation of patients with complex urinary tract infections. Biology. 2024; 13(4):257. [Crossref]
  41. Mattoo TK, Shaikh N, Nelson CP. Contemporary management of urinary tract infection in children. Pediatrics. 2021;147(2):e2020012138. [Crossref]
  42. Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents . 2011;38(Suppl):42-50. [Crossref]
  43. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2024.
  44. [Link]
  45. O'Donovan DJ. Urinary tract infections in neonates. In: UpToDate, Connor RF (Ed), Wolters Kluwer. (Accessed on June 2, 2024.)
  46. Pammi M. Treatment of Candida infection in neonates. In: UpToDate, Connor RF (Ed), Wolters Kluwer. (Accessed on June 2, 2024.)
  47. Shaikh N, Mattoo TK, Keren R, Ivanova A, Cui G, Moxey-Mims Met al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatr. 2016;170(9):848-54. [Crossref]
  48. Yolbaş I, Tekin R, Kelekci S, Tekin A, Okur MH, Ece A, et al. Community-acquired urinary tract infections in children: pathogens, antibiotic susceptibility and seasonal changes. Eur Rev Med Pharmacol Sci. 2013;17(7):971-6.
  49. Shaikh N, Hoberman A. Urinary tract infections in infants older than one month and young children: acute management, imaging, and prognosis. In: UpToDate, Connor RF (Ed), Wolters Kluwer. (Accessed on June 2, 2024).
  50. Gunduz S, Uludağ Altun H. Antibiotic resistance patterns of urinary tract pathogens in Turkish children. Glob Health Res Policy. 2018;3:10-5. [Crossref]
  51. Urinary tract infection in under 16s: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); July 27, 2022.
  52. Şimşek B, Şenbayrak S, Balık R. Trends in antimicrobial resistance and demographics of urinary tract infections regarding impacts of urological comorbidities in children in a single institution over a 4-year period. Turk J Nephrol. 2023;32:73-80. [Crossref]
  53. Robinson JL, Finlay JC, Lang ME, Bortolussi R, Canadian Paediatric Society, Infectious Diseases and Immunization Committee, Community Paediatrics Committee. Urinary tract infections in infants and children: diagnosis and management. Paediatr Child Health. 2014;19(6):315-25. [Crossref]
  54. Michael M, Hodson EM, Craig JC, Martin S, Moyer VA. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev. 2003;(1):CD003966. [Crossref]
  55. Shaikh N, Morone NE, Lopez J, Chianese J, Sangvai S, D'Amico V, et al. Does this child have a urinary tract infection? JAMA. 2007;298(24):2895-904. [Crossref]
  56. Palazzi DL, Campbell JR. Acute infectious cystitis: Management and prognosis in children older than two years and adolescents. In: UpToDate, Connor RF (Ed), Wolters Kluwer. (Accessed on June 2, 2024.)
  57. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, et al. The changing pattern of antimicrobial resistance within Escherichia coli isolates from nosocomial, community and urology patient- specific urinary tract infections, Dublin, 1999-2009. BJU Int. 2012;109:1198-206. [Crossref]
  58. Tanrıverdi Çaycı Y, Karacan G, Yoosefi M, Bilgin K, Gür Vural D, Bırıncı A. Çocuklarda idrar kültüründen izole edilen gram-negatif bakterilerin ve antibiyotik duyarlılıklarının retrospektif olarak değerlendirilmesi. Ahi Evran Med J. 2022;6(2):168-73. [Crossref]
  59. Garcia-Fulgueiras V, Caiata L, Bado I, Giachetto G, Robino L. Antibiotic susceptibility and fosfomycin resistance characterization in a cohort of children older than 6 years of age with urinary tract infection. Rev Argent Microbiol. 2022;54(2):120-4. [Crossref]
  60. Vazourasa K, Tassioue VI, Anastasiou-Katsiardanif A, Athanasopouloug K, Barbounih A. Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. J Global Antimicrob Res. 2020; 20:4-10. [Crossref]
  61. Dejonckheere Y, Desmet S, Knops N. A study of the 20‑year evolution of antimicrobial resistance patterns of pediatric urinary tract infections in a single center. European Journal of Pediatrics. 2022;181:3271-81. [Crossref]
  62. Fox MT, Amoah J, Hsu AJ, Herzke CA, Gerber JS, Tamma PD. Comparative effectiveness of antibiotic treatment duration in children with pyelonephritis. JAMA Netw Open. 2020;3(5):e203951. [Crossref]